Diabetic nephropathy: Of mice and men

Advances in Chronic Kidney Disease

Volumn 12, Issue 2, 2005, Pages 128-145

  Breyer, Matthew D ^a   Böttinger, Erwin ^b   Brosius III, Frank C ^b   Coffman, Thomas M ^b   Fogo, Agnes ^b   Harris, Raymond C ^b   Heilig, Charles W ^b   Sharma, Kumar ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Albuminuria; Glomerular filtration; Inbred mice; Rate; Streptozotocin

Indexed keywords

APOLIPOPROTEIN E; CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; BLOOD PRESSURE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETICS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; LIPID DIET; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; TRANSGENIC MOUSE;

EID: 16844365351     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.01.004     Document Type: Article

References (222)

1. USRDS USRDS The United States Renal Data System Am J Kidney Dis 42 2003 1 230
2. B.A. Young, C. Maynard, E.J. Boyko Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans Diabetes Care 26 2003 2392 2399
3. L. Tarnow, P. Rossing, F.S. Nielsen Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy Diabetes Care 23 2000 30 33
4. S.L. Jeffcoate Diabetes control and complications The role of glycated haemoglobin, 25 years on Diabet Med 21 2004 657 665
5. R.J. McCarter, J.M. Hempe, R. Gomez Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes Diabetes Care 27 2004 1259 1264
6. E.R. Seaquist, F.C. Goetz, S. Rich Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy [see comments] N Engl J Med 320 1989 1161 1165
7. A.S. Krolewski Genetics of diabetic nephropathy Evidence for major and minor gene effects [clinical conference] Kidney Int 55 1999 1582 1596
8. S.K. Iyengar, K.A. Fox, M. Schachere Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy J Am Soc Nephrol 14 2003 S195 S201
9. J.D. Marshall, J.L. Mu, Y.C. Cheah The AXB and BXA set of recombinant inbred mouse strains Mamm Genome 3 1992 669 680
10. J.A. Beck, S. Lloyd, M. Hafezparast Genealogies of mouse inbred strains Nat Genet 24 2000 23 25
11. R.H. Waterston, K. Lindblad-Toh, E. Birney Initial sequencing and comparative analysis of the mouse genome Nature 420 2002 520 562
12. E. Marshall Genome sequencing. Celera assembles mouse genome; public labs plan new strategy Science 292 2001 822
13. E. Marshall Genome sequencing. Public group completes draft of the mouse Science 296 2002 1005
14. S.K. Bronson, O. Smithies Altering mice by homologous recombination using embryonic stem cells J Biol Chem 269 1994 27155 27158
15. C. Babinet Transgenic mice An irreplaceable tool for the study of mammalian development and biology J Am Soc Nephrol 11 suppl 16 2000 S88 S94
16. A. Mansouri Determination of gene function by homologous recombination using embryonic stem cells and knockout mice Methods Mol Biol 175 2001 397 413
17. D.J. Townley, B.J. Avery, B. Rosen Rapid sequence analysis of gene trap integrations to generate a resource of insertional mutations in mice Genome Res 7 1997 293 298
18. P.A. Leighton, K.J. Mitchell, L.V. Goodrich Defining brain wiring patterns and mechanisms through gene trapping in mice Nature 410 2001 174 179
19. M.H. Hrabe de Angelis, H. Flaswinkel, H. Fuchs Genome-wide, large-scale production of mutant mice by ENU mutagenesis Nat Genet 25 2000 444 447
20. B. Paigen, D. Mitchell, P.A. Holmes Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice Biochem Genet 25 1987 881 892
21. K. DiPetrillo, S.W. Tsaih, S. Sheehan Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice Physiol Genomics 17 2004 215 220
22. F. Sugiyama, K. Yagami Ki, B. Paigen Mouse models of blood pressure regulation and hypertension Curr Hypertens Rep 3 2001 41 48
23. C.E. Mogensen The effect of blood pressure intervention on renal function in insulin-dependent diabetes Diabetes Metab 15 1989 343 351
24. M.L. Caramori, P. Fioretto, M. Mauer The need for early predictors of diabetic nephropathy risk Is albumin excretion rate sufficient? Diabetes 49 2000 1399 1408
25. C.E. Mogensen Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes J Intern Med 254 2003 45 66
26. M.T. Velasquez, P.L. Kimmel, O.E. Michaelis Animal models of spontaneous diabetic kidney disease FASEB J 4 1990 2850 2859
27. K. Sharma, P. McCue, S.R. Dunn Diabetic kidney disease in the db/db mouse Am J Physiol Renal Physiol 284 2003 F1138 F1144
28. B.M. Chavers, R.W. Bilous, E.N. Ellis Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria [see comments] N Engl J Med 320 1989 966 970
29. S.M. Mauer, P. Lane, D. Zhu Renal structure and function in insulin-dependent diabetes mellitus in man J Hypertens Suppl 10 1992 S17 S20
30. S.M. Mauer, M.W. Steffes, E.N. Ellis Structural-functional relationships in diabetic nephropathy J Clin Invest 74 1984 1143 1155
31. S. Rudberg, R. Osterby Decreasing glomerular filtration rate-an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents? Nephrol Dial Transplant 12 1997 1149 1154
32. C. Hasslacher, E. Ritz, J. Terpstra Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure Hypertension 7 1985 II74 II78
33. P. Jacobsen, K. Rossing, L. Tarnow Progression of diabetic nephropathy in normotensive type 1 diabetic patients Kidney Int Suppl 71 1999 S101 S105
34. A.S. Krolewski, L.M. Laffel, M. Krolewski Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus [see comments] N Engl J Med 332 1995 1251 1255
35. DCCT The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
36. K. Dan, H. Fujita, Y. Seto Relation between stable glycated hemoglobin A1C and plasma glucose levels in diabetes-model mice Exp Anim 46 1997 135 140
37. K.P. Peterson, J.G. Pavlovich, D. Goldstein What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry Clin Chem 44 1998 1951 1958
38. M.J. McDonald, R. Shapiro, M. Bleichman Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis J Biol Chem 253 1978 2327 2332
39. E.S. Kilpatrick Glycated haemoglobin in the year 2000 J Clin Pathol 53 2000 335 339
40. E. Fujii, T. Nomoto Changes in glycosylated hemoglobin in short- and semi long-term streptozotocin-diabetic mice and rats Jpn J Pharmacol 34 1984 113 115
41. K. Kaku, F.T. Fiedorek Jr, M. Province Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control Diabetes 37 1988 707 713
42. P.U. Dubuc, B.K. Scott, C.M. Peterson Sex differences in glycated hemoglobin in diabetic and non-diabetic C57BL/6 mice Diabetes Res Clin Pract 21 1993 95 101
43. M.H. Meyer, R.A. Meyer Jr, R.W. Gray Picric acid methods greatly overestimate serum creatinine in mice More accurate results with high-performance liquid chromatography Anal Biochem 144 1985 285 290
44. M.P. O'Donnell, M. Burne, F. Daniels Utility and limitations of serum creatinine as a measure of renal function in experimental renal ischemia-reperfusion injury Transplantation 73 2002 1841 1844
45. K. Jung, C. Wesslau, F. Priem Specific creatinine determination in laboratory animals using the new enzymatic test kit "Creatinine-PAP." J Clin Chem Clin Biochem 25 1989 357 361
46. F.A. Kemperman, J. Silberbusch, E.H. Slaats Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion Relevance of the creatinine assay Nephrol Dial Transplant 14 1999 1247 1251
47. F.A. Kemperman, J.A. Weber, J. Gorgels The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis J Intern Med 248 2000 511 517
48. S.K. Gerard, H. Khayam-Bashi Characterization of creatinine error in ketotic patients. A prospective comparison of alkaline picrate methods with an enzymatic method Am J Clin Pathol 84 1985 659 664
49. P.S. Yuen, S.R. Dunn, T. Miyaji A simplified method for HPLC determination of creatinine in mouse serum Am J Physiol Renal Physiol 286 2004 F1116 F1119
50. S.R. Dunn, Z. Qi, E.P. Bottinger Utility of endogenous creatinine clearance as a measure of renal function in mice Kidney Int 65 2004 1959 1967
51. Z. Qi, I. Whitt, A. Mehta Determination of glomerular filtration rate in conscious mice using FITC-inulin clearance Am J Physiol Renal Physiol 286 2004 F590 F596
52. J.N. Lorenz, E. Gruenstein A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin Am J Physiol 276 1999 F172 F177
53. W.T. Noonan, J.N. Lorenz Clearance studies in genetically altered mice Methods Mol Med 86 2003 315 327
54. H. Hackbarth, J. Lunebrink [Determination of the mouse glomerular filtration rate by total 51Cr- EDTA plasma slope clearance depending on age and sex] Z Versuchstierkd 21 1979 38 46
55. H. Hackbarth, D. Hackbarth Genetic analysis of renal function in mice. 1. Glomerular filtration rate and its correlation with body and kidney weight Lab Anim 15 1981 267 272
56. K. Gartner Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (c57bl/6j db/db and c57bl/ksj db/db) Diabetologia 15 1978 59 63
57. S. Zheng, W.T. Noonan, N.S. Metreveli Development of late-stage diabetic nephropathy in OVE26 diabetic mice Diabetes 53 2004 3248 3257
58. H.H. Parving, A.R. Andersen, U.M. Smidt Diabetic nephropathy and arterial hypertension Diabetologia 24 1983 10 12
59. H.H. Parving, A.R. Andersen, U.M. Smidt Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment Diabetes 32 suppl 2 1983 83 87
60. J.H. Krege, S.W. John, L.L. Langenbach Male-female differences in fertility and blood pressure in ACE- deficient mice Nature 375 1995 146 148
61. E. Mills, C.M. Kuhn, M.N. Feinglos Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus Am J Physiol 264 1993 R73 R78
62. W. Huang, Y. Gallois, N. Bouby Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse Proc Natl Acad Sci U S A 98 2001 13330 13334
63. M. Kakoki, N. Takahashi, J.C. Jennette Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor Proc Natl Acad Sci U S A 101 2004 13302 13305
64. J.S. Finlayson, R. Asofsky, M. Potter Major urinary protein complex of normal mice Origin Science 149 1965 981 982
65. K. Shahan, M. Denaro, M. Gilmartin Expression of six mouse major urinary protein genes in the mammary, parotid, sublingual, submaxillary, and lachrymal glands and in the liver Mol Cell Biol 7 1987 1947 1954
66. P.H. Yu, M. Wang, Y.L. Deng Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet Diabetologia 45 2002 1255 1262
67. P. Fioretto, M.W. Steffes, M. Mauer Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria Diabetes 43 1994 1358 1364
68. S.W. Hong, M. Isono, S. Chen Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse Am J Pathol 158 2001 1653 1663
69. M. Fujimoto, Y. Maezawa, K. Yokote Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy Biochem Biophys Res Commun 305 2003 1002 1007
70. S.M. Hammad, D.J. Hazen-Martin, M. Sohn Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes Kidney Blood Press Res 26 2003 351 361
71. E.C. Carlson, J.L. Audette, L.M. Klevay Ultrastructural and functional analyses of nephropathy in calmodulin-induced diabetic transgenic mice Anat Rec 247 1997 9 19
72. C. Lewis, A.R. Barbiers Streptozotocin, a new antibiotic. In vitro and in vivo evaluation Antibiot Annu 7 1959 247 254
73. G.L. Wilson, E.H. Leiter Streptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes Curr Top Microbiol Immunol 156 1990 27 54
74. E.H. Leiter Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice Influence of inbred background, sex, and thymus Proc Natl Acad Sci U S A 79 1982 630 634
75. M. Hosokawa, W. Dolci, B. Thorens Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin Biochem Biophys Res Commun 289 2001 1114 1117
76. S. Itagaki, E. Nishida, M.J. Lee Histopathology of subacute renal lesions in mice induced by streptozotocin Exp Toxicol Pathol 47 1995 485 491
77. A.G. Farr, J.W. Mannschreck, S.K. Anderson Expression of Ia antigens by murine kidney epithelium after exposure to streptozotocin Am J Pathol 126 1987 561 568
78. P. Schmezer, C. Eckert, U.M. Liegibel Tissue-specific induction of mutations by streptozotocin in vivo Mutat Res 307 1994 495 499
79. M. Katoh, Y. Ohmachi, Y. Kurosawa Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice Eur J Pharmacol 398 2000 381 387
80. M. Awazu, S. Omori, K. Ishikura The lack of cyclin kinase inhibitor p27Kip1 ameliorates progression of diabetic nephropathy J Am Soc Nephrol 14 2003 699 708
81. A.A. Like, M.C. Appel, R.M. Williams Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies Lab Invest 38 1978 470 486
82. A.A. Like, A.A. Rossini Streptozotocin-induced pancreatic insulitis New model of diabetes mellitus Science 193 1976 415 417
83. E.H. Leiter Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment Curr Top Microbiol Immunol 122 1985 78 85
84. A.A. Rossini, M.C. Appel, R.M. Williams Genetic influence of the streptozotocin-induced insulitis and hyperglycemia Diabetes 26 1977 916 920
85. C.E. Mathews, S.H. Langley, E.H. Leiter New mouse model to study islet transplantation in insulin-dependent diabetes mellitus Transplantation 73 2002 1333 1336
86. J. Wang, T. Takeuchi, S. Tanaka A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse J Clin Invest 103 1999 27 37
87. M. Yoshioka, T. Kayo, T. Ikeda A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice Diabetes 46 1997 887 894
88. D. Ron Proteotoxicity in the endoplasmic reticulum lessons from the Akita diabetic mouse J Clin Invest 109 2002 443 445
89. T. Haseyama, T. Fujita, F. Hirasawa Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse Tohoku J Exp Med 198 2002 233 244
90. H. Fujita, T. Haseyama, T. Kayo Increased expression of glutathione S-transferase in renal proximal tubules in the early stages of diabetes A study of type-2 diabetes in the Akita mouse model Exp Nephrol 9 2001 380 386
91. M. Kanauchi, T. Kawano, K. Dohi Serum IgA levels in patients with diabetic nephropathy and IgA nephropathy superimposed on diabetes mellitus Diabetes Res Clin Pract 48 2000 113 118
92. L.L. Miller, M.J. Izzo, D. Wemett Increased plasma IgA, sIgA, and C3- and IgA-containing immune complexes with renal glomerular deposits in diabetic rats Diabetes 37 1988 185 193
93. S.K. Ainsworth, H.Z. Hirsch, N.C. Brackett Jr Diabetic glomerulonephropathy histopathologic, immunofluorescent, and ultrastructural studies of 16 cases Hum Pathol 13 1982 470 478
94. E.Y. Lee, C.H. Chung, S.O. Choi Immunoglobulin A nephropathy in patients with non-insulin dependent diabetes mellitus J Korean Med Sci 14 1999 582 585
95. H. Kolb Mouse models of insulin dependent diabetes Low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice Diabetes Metab Rev 3 1987 751 778
96. S. Makino, K. Kunimoto, Y. Muraoka Breeding of a non-obese, diabetic strain of mice Jikken Dobutsu 29 1980 1 13
97. J. Miyagawa, T. Hanafusa, A. Miyazaki Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse Virchows Arch B Cell Pathol Incl Mol Pathol 51 1986 215 225
98. M.J. Cameron, C. Meagher, T.L. Delovitch Failure in immune regulation begets IDDM in NOD mice Diabetes Metab Rev 14 1998 177 185
99. E.H. Leiter, M. Prochazka, D.L. Coleman The non-obese diabetic (NOD) mouse Am J Pathol 128 1987 380 383
100. M.A. Atkinson, E.H. Leiter The NOD mouse model of type 1 diabetes As good as it gets? Nat Med 5 1999 601 604
101. H. Acha-Orbea, L. Scarpellino Nonobese diabetic and nonobese nondiabetic mice have unique MHC class II haplotypes Immunogenetics 34 1991 57 59
102. Y. Watanabe, Y. Itoh, F. Yoshida Unique glomerular lesion with spontaneous lipid deposition in glomerular capillary lumina in the NON strain of mice Nephron 58 1991 210 218
103. T. Doi, M. Hattori, L.Y. Agodoa Glomerular lesions in nonobese diabetic mouse Before and after the onset of hyperglycemia Lab Invest 63 1990 204 212
104. C.J. He, F. Zheng, A. Stitt Differential expression of renal AGE-receptor genes in NOD mice Possible role in nonobese diabetic renal disease Kidney Int 58 2000 1931 1940
105. S.A. Schreyer, D.L. Wilson, R.C. LeBoeuf C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis Atherosclerosis 136 1998 17 24
106. K. Sharma, F.N. Ziyadeh Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse Am J Physiol 267 1994 F1094-F1001
107. O.G. Pankewycz, J.X. Guan, W.K. Bolton Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells Kidney Int 46 1994 748 758
108. R.S. Surwit, M.N. Feinglos, J. Rodin Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice Metabolism 44 1995 645 651
109. R.S. Surwit, C.M. Kuhn, C. Cochrane Diet-induced type II diabetes in C57BL/6J mice Diabetes 37 1988 1163 1167
110. A.E. Petro, J. Cotter, D.A. Cooper Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse Metabolism 53 2004 454 457
111. D.A. Towler, M. Bidder, T. Latifi Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice J Biol Chem 273 1998 30427 30434
112. J.L. Mu, J.K. Naggert, K.L. Svenson Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J J Lipid Res 40 1999 1328 1335
113. W.T. Noonan, R.O. Banks Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus Proc Soc Exp Biol Med 225 2000 221 230
114. H. Chen, O. Charlat, L.A. Tartaglia Evidence that the diabetes gene encodes the leptin receptor Identification of a mutation in the leptin receptor gene in db/db mice Cell 84 1996 491 495
115. G.H. Lee, R. Proenca, J.M. Montez Abnormal splicing of the leptin receptor in diabetic mice Nature 379 1996 632 635
116. J.K. Naggert, J.L. Mu, W. Frankel Genomic analysis of the C57BL/Ks mouse strain Mamm Genome 6 1995 131 133
117. S.M. Lee, R. Bressler Prevention of diabetic nephropathy by diet control in the db/db mouse Diabetes 30 1981 106 111
118. S.M. Lee, G. Tutwiler, R. Bressler Metabolic control of prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db) Diabetes 31 1982 12 18
119. A.A. Like, R.L. Lavine, P.L. Poffenbarger Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria Am J Pathol 66 1972 193 224
120. M.P. Cohen, G.T. Lautenslager, C.W. Shearman Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice Metabolism 50 2001 1435 1440
121. K. Arakawa, T. Ishihara, A. Oku Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095 Br J Pharmacol 132 2001 578 586
122. R. Mishra, S.N. Emancipator, C. Miller Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney Am J Physiol Renal Physiol 286 2004 F913 F921
123. D. Koya, M. Haneda, H. Nakagawa Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J 14 2000 439 447
124. T.S. Ha, J.L. Barnes, J.L. Stewart Regulation of renal laminin in mice with type II diabetes J Am Soc Nephrol 10 1999 1931 1939
125. F.N. Ziyadeh, B.B. Hoffman, D.C. Han Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice [see comments] Proc Natl Acad Sci U S A 97 2000 8015 8020
126. R.J. Koenig, D.C. Araujo, A. Cerami Increased hemoglobin AIc in diabetic mice Diabetes 25 1976 1 5
127. E.H. Leiter, D.L. Coleman, K.P. Hummel The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex Diabetes 30 1981 1029 1034
128. C.J. Meade, D.R. Brandon, W. Smith The relationship between hyperglycaemia and renal immune complex deposition in mice with inherited diabetes Clin Exp Immunol 43 1981 109 120
129. E.H. Leiter, P.H. Le, D.L. Coleman Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice Control by gender-associated, MHC-unlinked traits Immunogenetics 26 1987 6 13
130. E.H. Leiter, H.D. Chapman, D.L. Coleman The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia Endocrinology 124 1989 912 922
131. F. Chow, E. Ozols, D.J. Nikolic-Paterson Macrophages in mouse type 2 diabetic nephropathy Correlation with diabetic state and progressive renal injury Kidney Int 65 2004 116 128
132. F. Zheng, F. Cornacchia, I. Schulman Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow The role of mesangial cell progenitors Diabetes 53 2004 2420 2427
133. S.C. Chua Jr, W.K. Chung, X.S. Wu-Peng Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor Science 271 1996 994 996
134. R.L. Leibel And finally, genes for human obesity Nat Genet 16 1997 218 220
135. S. Chua Jr, S.M. Liu, Q. Li Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB- Lepr (db)) and obese (DBA- Lep (ob)) mice Diabetologia 45 2002 976 990
136. D. Lu, D. Willard, I.R. Patel Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor Nature 371 1994 799 802
137. M.M. Ollmann, B.D. Wilson, Y.K. Yang Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein Science 278 1997 135 138
138. R.J. Miltenberger, R.L. Mynatt, J.E. Wilkinson The role of the agouti gene in the yellow obese syndrome J Nutr 127 1997 1902S 1907S
139. E.J. Michaud, S.J. Bultman, M.L. Klebig A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation Proc Natl Acad Sci U S A 91 1994 2562 2566
140. H. Ninomiya, T. Inomata, K. Ogihara Obstructive uropathy and hydronephrosis in male KK-Ay mice A report of cases J Vet Med Sci 61 1999 53 57
141. H. Ninomiya, T. Inomata, K. Ogihara Microvasculature of hydronephrotic kidneys in KK-A(Y) mice J Vet Med Sci 62 2000 1093 1098
142. E.H. Leiter, P.C. Reifsnyder Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes Diabetes 53 suppl 1 2004 S4 S11
143. R.A. Koza, K. Flurkey, D.M. Graunke Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity Metabolism 53 2004 799 808
144. P.C. Reifsnyder, E.H. Leiter Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice Diabetes 51 2002 825 832
145. K.A. Melez, L.C. Harrison, J.N. Gilliam Diabetes is associated with autoimmunity in the New Zealand obese (NZO) mouse Diabetes 29 1980 835 840
146. R. Korstanje, K. DiPetrillo Unraveling the genetics of chronic kidney disease using animal models Am J Physiol Renal Physiol 287 2004 F347 F352
147. L.J. Ma, A.B. Fogo Model of robust induction of glomerulosclerosis in mice Importance of genetic background Kidney Int 64 2003 350 355
148. F. Zheng, G.E. Striker, C. Esposito Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice Kidney Int 54 1998 1999 2007
149. F. Giacomelli, J. Wiener Primary myocardial disease in the diabetic mouse. An ultrastructural study Lab Invest 40 1979 460 473
150. K. Doi, H. Matsuzaki, T. Tsuda Rapid development of renal lesions in diabetic DBA mice infected with the D-variant of encephalomyocarditis virus (EMC-D) Br J Exp Pathol 70 1989 275 281
151. K. Shichinohe, M. Shimizu, M. Ishizaki Kidney complications in EMC virus-induced diabetes in conventional DBA/2 male mice Jikken Dobutsu 39 1990 113 116
152. P.M. Nishina, J. Wang, W. Toyofuku Atherosclerosis and plasma and liver lipids in nine inbred strains of mice Lipids 28 1993 599 605
153. E.A. Kirk, G.L. Moe, M.T. Caldwell Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice Searching for level and variability genes J Lipid Res 36 1995 1522 1532
154. S.R. Brunnert Morphologic response of myocardium to freeze-thaw injury in mouse strains with dystrophic cardiac calcification Lab Anim Sci 47 1997 11 18
155. S.R. Brunnert, N.H. Altman Dystrophic cardiac calcinosis in mice Abnormal myocardial response to freeze-thaw injury Lab Anim Sci 40 1990 616 619
156. A. Hartner, N. Cordasic, B. Klanke Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice Nephrol Dial Transplant 18 2003 1999 2004
157. R.K. Zalups The Os/+ mouse A genetic animal model of reduced renal mass Am J Physiol 264 1993 F53 F60
158. A. Fornoni, O. Lenz, L.J. Striker Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice Diabetes 52 2003 2594 2602
159. F. Cornacchia, A. Fornoni, A.R. Plati Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors J Clin Invest 108 2001 1649 1656
160. C. Esposito, C.J. He, G.E. Striker Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice Am J Pathol 154 1999 891 897
161. O. Lenz, F. Zheng, J. Vilar The inheritance of glomerulosclerosis in mice is controlled by multiple quantitative trait loci Nephrol Dial Transplant 13 1998 3074 3078
162. P.N. Epstein, P.A. Overbeek, A.R. Means Calmodulin-induced early-onset diabetes in transgenic mice Cell 58 1989 1067 1073
163. P.N. Epstein, T.J. Ribar, G.L. Decker Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice Endocrinology 130 1992 1387 1393
164. K. Kondo, K. Nozawa, T. Romida Inbred strains resulting from Japanese mice Bull Exp Anim 6 1957 107 112
165. A.S. Reddi, W. Oppermann, C.A. Velasco Diabetic microangiopathy in KK mice. II. Suppression of glomerulosclerosis by pyridinolcarbamate Exp Mol Pathol 26 1997 325 339
166. A.S. Reddi, H. Wehner, M.Y. Khan Kidney disease in KK mice Structural, biochemical and functional relationships Adv Exp Med Biol 246 1988 135 145
167. J. Suto, S. Matsuura, K. Imamura Genetic analysis of non-insulin- dependent diabetes mellitus in KK and KK-Ay mice Eur J Endocrinol 139 1998 654 661
168. J. Liao, M. Kobayashi, Y. Kanamuru Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice J Nephrol 16 2003 841 849
169. R.A. Camerini-Davalos, W. Oppermann, G. Treser Glomerulosclerosis in a strain of genetically diabetic mice Diabetes 17 1968 301
170. A.S. Reddi, C.A. Velasco, P.R. Reddy Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis Exp Mol Pathol 53 1990 140 151
171. T.J. Allen, M.E. Cooper, H.Y. Lan Use of genetic mouse models in the study of diabetic nephropathy Curr Atheroscler Rep 6 2004 197 202
172. A.J. Jenkins, T.J. Lyons, D. Zheng Lipoproteins in the DCCT/EDIC cohort Associations with diabetic nephropathy Kidney Int 64 2003 817 828
173. E. Liberopoulos, K. Siamopoulos, M. Elisaf Apolipoprotein E and renal disease Am J Kidney Dis 43 2004 223 233
174. R.W. Mahley Apolipoprotein E Cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
175. G. Utermann Apolipoprotein E polymorphism in health and disease Am Heart J 113 1987 433 440
176. R.W. Mahley, Y. Huang Apolipoprotein E From atherosclerosis to Alzheimer's disease and beyond Curr Opin Lipidol 10 1999 207 217
177. S. Araki, D. Koya, T. Makiishi APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes Results of a prospective observational follow-up study Diabetes Care 26 2003 2416 2420
178. M. Eto, M. Saito, M. Okada Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients Am J Kidney Dis 40 2002 243 251
179. T.J. Orchard, Y.F. Chang, R.E. Ferrell Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study Kidney Int 62 2002 963 970
180. N.S. Shcherbak Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in type I diabetes Case-control study BMC Med Genet 2 2001 8
181. S. Hadjadj, Y. Gallois, G. Simard Genetique de la Nephropathie Diabetique Study Group Donnees Epidemiologiques sur le Syndrome d'Insulino-Resistance Study Group Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein Nephrol Dial Transplant 15 2001 1971 1976
182. L. Tarnow, C.D. Stehouwer, J.J. Emeis Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy Nephrol Dial Transplant 15 2000 625 630
183. T.A. Chowdhury, P.H. Dyer, S. Kumar Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM Diabetes 47 1998 278 280
184. E. Werle, W. Fiehn, C. Hasslacher Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients Diabetes Care 21 1998 994 998
185. R. Boizel, P.Y. Benhamou, P. Corticelli ApoE polymorphism and albuminuria in diabetes mellitus A role for LDL in the development of nephropathy in NIDDM? Nephrol Dial Transplant 13 1998 72 75
186. T. Onuma, L.M. Laffel, M.C. Angelico Apolipoprotein E genotypes and risk of diabetic nephropathy J Am Soc Nephrol 7 1996 1075 1078
187. M. Eto, K. Horita, A. Morikawa Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy Clin Genet 48 1995 288 292
188. A.S. Plump, J.D. Smith, T. Hayek Severe hypercholesterolemia and atherosclerosis in apolipoprotein E- deficient mice created by homologous recombination in ES cells Cell 71 1992 343 353
189. M. Lassila, K.K. Seah, T.J. Allen Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse Role of advanced glycation end products J Am Soc Nephrol 15 2004 2125 2138
190. M. Brownlee, A. Cerami, H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 1315 1321
191. T. Wendt, N. Tanji, J. Guo Glucose, glycation, and RAGE implications for amplification of cellular dysfunction in diabetic nephropathy J Am Soc Nephrol 14 2003 1383 1395
192. M.D. Oldfield, L.A. Bach, J.M. Forbes Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) J Clin Invest 108 2001 1853 1863
193. J.H. Li, W. Wang, X.R. Huang Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway Am J Pathol 164 2004 1389 1397
194. T.M. Wendt, N. Tanji, J. Guo RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of
195. Y. Yamamoto, I. Kato, T. Doi Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice J Clin Invest 108 2001 261 268
196. T. Nakayama, M. Soma, Y. Takahashi Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese Clin Genet 51 1997 26 30
197. R. Arngrimsson, C. Hayward, S. Nadaud Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region Am J Hum Genet 61 1997 354 362
198. K. Yokoyama, T. Tsukada, H. Matsuoka High accumulation of endothelial nitric oxide synthase (ecNOS) A gene polymorphism in patients with end-stage renal disease Nephron 79 1998 360 361
199. M. Yoshimura, H. Yasue, M. Nakayama A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese Hum Genet 103 1998 65 69
200. Y. Miyamoto, Y. Saito, N. Kajiyama Endothelial nitric oxide synthase gene is positively associated with essential hypertension Hypertension 32 1998 3 8
201. P. Ksiazek, P. Wojewoda, K. Muc Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus Mol Diagn 7 2003 119 123
202. D. Frost, J. Chitu, M. Meyer Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients Exp Clin Endocrinol Diabetes 111 2003 12 15
203. A. Zanchi, D.K. Moczulski, L.S. Hanna Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism Kidney Int 57 2000 405 413
204. S. Neugebauer, T. Baba, T. Watanabe Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes Diabetes 49 2000 500 503
205. C. Li, Y. Dong, W. Lu [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy] Zhonghua Nei Ke Za Zhi 40 2001 729 732
206. Y. Asakimori, N. Yorioka, I. Yamamoto Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease Nephron 89 2001 219 223
207. E. Noiri, H. Satoh, J. Taguchi Association of eNOS Glu298Asp polymorphism with end-stage renal disease Hypertension 40 2002 535 540
208. S. Lin, H. Qu, M. Qiu Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population Nephron 91 2002 768
209. T. Shimizu, T. Onuma, R. Kawamori Endothelial nitric oxide synthase gene and the development of diabetic nephropathy Diabetes Res Clin Pract 58 2002 179 185
210. J.D. Rippin, A. Patel, N.D. Belyaev Nitric oxide synthase gene polymorphisms and diabetic nephropathy Diabetologia 46 2003 426 428
211. B. Degen, S. Schmidt, E. Ritz A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy Nephrol Dial Transplant 16 2001 185
212. B.I. Freedman, H. Yu, P.J. Anderson Genetic analysis of nitric oxide and endothelin in end-stage renal disease Nephrol Dial Transplant 15 2000 1794 1800
213. J.W. Knowles, R.L. Reddick, J.C. Jennette Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment J Clin Invest 105 2000 451 458
214. P.J. Kuhlencordt, R. Gyurko, F. Han Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454
215. J. Chen, P.J. Kuhlencordt, J. Astern Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice Circulation 104 2001 2391 2394
216. M. Ozaki, S. Kawashima, T. Yamashita Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice J Clin Invest 110 2002 331 340
217. C. Weigert, K. Brodbeck, F.C. Brosius 3rd Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters Diabetes 52 2003 527 535
218. C.W. Heilig, L.A. Concepcion, B.L. Riser Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype J Clin Invest 96 1995 1802 1814
219. C. Heilig, C. Zaloga, M. Lee Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney Lab Invest 73 1995 674 684
220. S. Chen, K.O. Heilig, F. Brosius III Diabetes increases glomerular GLUT1 and antisense-GLUT1 protects against diabetic glomerulosclerosis J Am Soc Nephrol 14 2003 46A (abstr)
221. C.W. Heilig, Y. Liu, R.L. England D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells Implications for diabetic nephropathy Diabetes 46 1997 1030 1039
222. K.O. Heilig, S. Chen, M. Xiang Transgenic overexpression of GLUT1 in glomeruli produces features of diabetic nephropathy in mice J Am Soc Nephrol 2004 (abstract)